We design special breeds of cannabis
for specific medical conditions.

We are a specialized genetics company that designs and develops custom cannabis breeds engineered specifically for targeted medical conditions. We focus exclusively on pharmaceutical applications using our proprietary super genetics.

Super genetics are our exclusive, proprietary cannabis strains developed through years of advanced breeding programs. They possess unique cannabinoid and terpene profiles that deliver superior, condition-specific therapeutic effects no other organization currently offers.

Using advanced selective breeding, genetic analysis, and controlled phenotyping, we isolate and enhance the exact cannabinoid and terpene combinations proven to interact with the biological pathways of each targeted medical condition.

Our genetics are customized for chronic pain, epilepsy, neurological disorders, anxiety and mood disorders, inflammatory conditions, sleep disorders, and many other specific medical needs. New condition-specific lines are developed regularly.

No. Our super genetics are supplied exclusively to licensed researchers, pharmaceutical partners, and authorized cultivators. We do not sell directly to individual patients or consumers.

Standard strains are general-purpose. Ours are precision-engineered using super genetics for consistent, condition-specific results with optimized ratios and higher therapeutic predictability.

Yes. Every breeding program is grounded in peer-reviewed science, laboratory testing, and ongoing collaboration with medical researchers and institutions.

We operate in full compliance with all federal, state, and local cannabis regulations. Our genetics are developed for use in approved research and pharmaceutical development programs.

No. We focus exclusively on B2B and research supply. Patients access our genetics only through licensed medical programs and authorized partners.

It is a multi-year process involving selective breeding across many generations, genetic sequencing, stability testing, and rigorous laboratory validation to ensure each strain is consistent and effective.

Our core team has over a decade of specialized experience in cannabis genetics. The current super genetics library represents more than eight years of continuous proprietary development.

Yes. We work directly with medical researchers and institutions to develop fully bespoke strains tailored to unique therapeutic requirements.

Every batch is tested in third-party ISO-accredited laboratories for potency, purity, heavy metals, pesticides, microbial safety, and genetic stability.

Our state-of-the-art facilities are located in California and operate under the strictest regulatory compliance for medical cannabis genetics research and development.

Research institutions, pharmaceutical companies, and licensed cultivators may contact us directly to discuss collaboration opportunities and access to our super genetics.

Individual responses vary. Our strains are optimized to maximize therapeutic benefit while minimizing unwanted effects. All use must be supervised by qualified medical professionals.

Our portfolio includes high-CBD, balanced THC/CBD, high-minor-cannabinoid, and specialized ratio strains — each engineered for the specific medical condition they target.

Superior therapeutic efficacy, genetic stability, disease resistance, high yield consistency, and unique molecular profiles that no other breeder currently offers anywhere in the world.

Yes. We actively support and collaborate on clinical research programs to validate the efficacy and safety of our specialized medical cannabis genetics.

Subscribe to our research newsletter or contact us directly. We regularly announce new condition-specific genetics exclusively for our licensed partners.